Abbott to Spin Off Nutrition Business Into Independent Company
Abbott Laboratories said it will issue shares to existing investors for an independent company housing its Similac nutrition business.
Abbott Laboratories said it plans to separate its nutrition business, a division that has faced a baby-formula contamination crisis, shortages and lawsuits in recent years. The company will distribute shares in the independent business to its existing investors. The new company will include Similac…